From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]
Meyer JM+4 more
europepmc +1 more source
Allosteric modulators of M1 muscarinic receptors enhance acetylcholine efficacy and decrease locomotor activity and turning behaviors in zebrafish [PDF]
Corey J. Widman+11 more
openalex +1 more source
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors [PDF]
Nara Lee+5 more
openalex +1 more source
Is muscarinic receptor agonist effective and tolerant for schizophrenia? [PDF]
Guo X, Deng R, Lai J, Hu S.
europepmc +1 more source
Evaluation of the Alterations in Central Cholinergic Neurotransmission in Aging and Amyloid Precursor Protein Knock-In Mice. [PDF]
Nagai-Arakawa I+14 more
europepmc +1 more source
Review for "M1 muscarinic acetylcholine receptor‐mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons" [PDF]
Griffith Wh
openalex +1 more source
The potential of repurposing clemastine to promote remyelination. [PDF]
Yamazaki R, Ohno N.
europepmc +1 more source
M1 muscarinic receptor‐mediated facilitation of acetylcholine release in the rat urinary bladder.
George T. Somogyi+2 more
openalex +1 more source
Myelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities. [PDF]
Huang Z+4 more
europepmc +1 more source